OnabotulinumtoxinA injections for idiopathic and neurogenic overactive bladder: discontinuation rates and reasons for treatment disruption

Arlandis Guzman S1, López-Fando Lavalle L2, Gallego A1, Fabuel Alcañiz J J2, Broseta E1, Jiménez-Cidre M A2

Research Type

Clinical

Abstract Category

Overactive Bladder

Abstract 169
Updates on the Use of Botulinum Toxin
Scientific Podium Short Oral Session 10
Wednesday 7th October 2015
14:45 - 14:52
210AE
Overactive Bladder Urgency Urinary Incontinence Pharmacology
1. HUP La Fe, 2. H Ramón y Cajal
Presenter
S

Salvador Arlandis Guzman
HUP La Fe
Links

Abstract

10/11/2024 03:18:30